VentriPoint Diagnostics Ltd.
VPTDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $104 | $0 | $71 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $11 | $11 | $0 | $0 |
| Gross Profit | $104 | -$11 | $71 | $0 |
| % Margin | 100% | – | 100% | – |
| R&D Expenses | $99 | $79 | $107 | $192 |
| G&A Expenses | $383 | $995 | $580 | $565 |
| SG&A Expenses | $651 | $1,090 | $811 | $860 |
| Sales & Mktg Exp. | $268 | $95 | $232 | $295 |
| Other Operating Expenses | -$223 | $0 | $0 | $0 |
| Operating Expenses | $528 | $1,168 | $918 | $1,051 |
| Operating Income | -$464 | -$1,168 | -$847 | -$1,051 |
| % Margin | -444.7% | – | -1,187% | – |
| Other Income/Exp. Net | -$106 | -$120 | -$113 | -$92 |
| Pre-Tax Income | -$752 | -$1,289 | -$960 | -$1,143 |
| Tax Expense | $0 | $0 | $0 | -$83 |
| Net Income | -$540 | -$1,289 | -$960 | -$1,060 |
| % Margin | -517.7% | – | -1,345.7% | – |
| EPS | -0.003 | -0.008 | -0.006 | -0.007 |
| % Growth | 59.5% | -33.9% | 10.6% | – |
| EPS Diluted | -0.003 | -0.008 | -0.006 | -0.007 |
| Weighted Avg Shares Out | 167,281 | 163,727 | 162,582 | 157,183 |
| Weighted Avg Shares Out Dil | 167,281 | 163,727 | 162,582 | 157,183 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $87 | $122 | $110 | $67 |
| Depreciation & Amortization | $15 | $15 | $15 | $15 |
| EBITDA | -$617 | -$1,152 | -$835 | -$1,058 |
| % Margin | -591.1% | – | -1,170.5% | – |